TY - JOUR
T1 - Characterizing Long COVID
T2 - Deep Phenotype of a Complex Condition
AU - Deer, Rachel R.
AU - Rock, Madeline A.
AU - Vasilevsky, Nicole
AU - Carmody, Leigh
AU - Rando, Halie
AU - Anzalone, Alfred J.
AU - Basson, Marc D.
AU - Bennett, Tellen D.
AU - Bergquist, Timothy
AU - Boudreau, Eilis A.
AU - Bramante, Carolyn T.
AU - Byrd, James Brian
AU - Callahan, Tiffany J.
AU - Chan, Lauren E.
AU - Chu, Haitao
AU - Chute, Christopher G.
AU - Coleman, Ben D.
AU - Davis, Hannah E.
AU - Gagnier, Joel
AU - Greene, Casey S.
AU - Hillegass, William B.
AU - Kavuluru, Ramakanth
AU - Kimble, Wesley D.
AU - Koraishy, Farrukh M.
AU - Köhler, Sebastian
AU - Liang, Chen
AU - Liu, Feifan
AU - Liu, Hongfang
AU - Madhira, Vithal
AU - Madlock-Brown, Charisse R.
AU - Matentzoglu, Nicolas
AU - Mazzotti, Diego R.
AU - McMurry, Julie A.
AU - McNair, Douglas S.
AU - Moffitt, Richard A.
AU - Monteith, Teshamae S.
AU - Parker, Ann M.
AU - Perry, Mallory A.
AU - Pfaff, Emily
AU - Reese, Justin T.
AU - Saltz, Joel
AU - Schuff, Robert A.
AU - Solomonides, Anthony E.
AU - Solway, Julian
AU - Spratt, Heidi
AU - Stein, Gary S.
AU - Sule, Anupam A.
AU - Topaloglu, Umit
AU - Vavougios, George D.
AU - Wang, Liwei
AU - Haendel, Melissa A.
AU - Robinson, Peter N.
N1 - Publisher Copyright:
© 2021 The Author(s)
PY - 2021/12
Y1 - 2021/12
N2 - Background: Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 (PASC or “long COVID”), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many phenotypic manifestations. Patient-led studies are of particular importance for understanding the natural history of COVID-19, but integration is hampered because they often use different terms to describe the same symptom or condition. This significant disparity in patient versus clinical characterization motivated the proposed ontological approach to specifying manifestations, which will improve capture and integration of future long COVID studies. Methods: The Human Phenotype Ontology (HPO) is a widely used standard for exchange and analysis of phenotypic abnormalities in human disease but has not yet been applied to the analysis of COVID-19. Findings: We identified 303 articles published before April 29, 2021, curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms. We present layperson synonyms and definitions that can be used to link patient self-report questionnaires to standard medical terminology. Long COVID clinical manifestations are not assessed consistently across studies, and most manifestations have been reported with a wide range of synonyms by different authors. Across at least 10 cohorts, authors reported 31 unique clinical features corresponding to HPO terms; the most commonly reported feature was Fatigue (median 45.1%) and the least commonly reported was Nausea (median 3.9%), but the reported percentages varied widely between studies. Interpretation: Translating long COVID manifestations into computable HPO terms will improve analysis, data capture, and classification of long COVID patients. If researchers, clinicians, and patients share a common language, then studies can be compared/pooled more effectively. Furthermore, mapping lay terminology to HPO will help patients assist clinicians and researchers in creating phenotypic characterizations that are computationally accessible, thereby improving the stratification, diagnosis, and treatment of long COVID. Funding: U24TR002306; UL1TR001439; P30AG024832; GBMF4552; R01HG010067; UL1TR002535; K23HL128909; UL1TR002389; K99GM145411.
AB - Background: Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 (PASC or “long COVID”), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many phenotypic manifestations. Patient-led studies are of particular importance for understanding the natural history of COVID-19, but integration is hampered because they often use different terms to describe the same symptom or condition. This significant disparity in patient versus clinical characterization motivated the proposed ontological approach to specifying manifestations, which will improve capture and integration of future long COVID studies. Methods: The Human Phenotype Ontology (HPO) is a widely used standard for exchange and analysis of phenotypic abnormalities in human disease but has not yet been applied to the analysis of COVID-19. Findings: We identified 303 articles published before April 29, 2021, curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to HPO terms. We present layperson synonyms and definitions that can be used to link patient self-report questionnaires to standard medical terminology. Long COVID clinical manifestations are not assessed consistently across studies, and most manifestations have been reported with a wide range of synonyms by different authors. Across at least 10 cohorts, authors reported 31 unique clinical features corresponding to HPO terms; the most commonly reported feature was Fatigue (median 45.1%) and the least commonly reported was Nausea (median 3.9%), but the reported percentages varied widely between studies. Interpretation: Translating long COVID manifestations into computable HPO terms will improve analysis, data capture, and classification of long COVID patients. If researchers, clinicians, and patients share a common language, then studies can be compared/pooled more effectively. Furthermore, mapping lay terminology to HPO will help patients assist clinicians and researchers in creating phenotypic characterizations that are computationally accessible, thereby improving the stratification, diagnosis, and treatment of long COVID. Funding: U24TR002306; UL1TR001439; P30AG024832; GBMF4552; R01HG010067; UL1TR002535; K23HL128909; UL1TR002389; K99GM145411.
KW - COVID-19
KW - human phenotype ontology
KW - long COVID
KW - of post-acute sequelae of SARS-CoV-2
KW - phenotyping
UR - http://www.scopus.com/inward/record.url?scp=85119906989&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119906989&partnerID=8YFLogxK
U2 - 10.1016/j.ebiom.2021.103722
DO - 10.1016/j.ebiom.2021.103722
M3 - Article
C2 - 34839263
AN - SCOPUS:85119906989
SN - 2352-3964
VL - 74
JO - EBioMedicine
JF - EBioMedicine
M1 - 103722
ER -